Amlodine

Quick links to important sections

Amlodine

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlodine

Quick Facts

Property Description
Active ingredient Amlodipine (often as Amlodipine besylate)
Form Oral tablet
Pharmacological class Calcium Channel Blocker (Dihydropyridine)
General purpose Reducing pressure in the arteries
Origin Synthetic derivative

What Type of Medicine is Amlodine?

Amlodine is a prescription-only medication whose active compound is Amlodipine, a substance chemically identified as a dihydropyridine derivative. Pharmacologically, it belongs to the major class of Calcium Channel Blockers (CCBs), a classification universally recognized in clinical practice. This synthetic drug functions as a long-acting, single-ingredient agent that operates throughout the body after oral administration. Amlodipine is often formulated as the stable salt, Amlodipine besylate, a specific formulation recognized for its reliable absorption and consistent long-acting profile. The drug’s class influences the foundational dynamics of blood flow.

Composition and Physical Form

Amlodipine is supplied primarily as an oral tablet, its designated route of administration, and is uniquely distinguished within its class by its prolonged half-life, making it suitable for once-daily dosing. The active ingredient, Amlodipine, is typically combined with pharmaceutical excipients necessary to create a stable, solid dosage form. Amlodipine has a long-standing use as a first-line agent, with an established efficacy profile for general cardiovascular support. Amlodipine is a well-understood and commonly utilized medication.

General Purpose and Action Principle

The core purpose of Amlodipine is to manage conditions associated with excessive tension in the blood vessels. It achieves this by acting as a powerful vasodilator, or blood vessel widener, facilitating vascular smooth muscle relaxation. This action reduces the systemic resistance to blood flow, thereby lowering the overall pressure the heart must work against. A typical, neutral scenario involves its use for the long-term maintenance of controlled blood pressure.

Regulatory References

  1. National Library of Medicine - NCBI Bookshelf

What side effects are possible with Amlodine?

Possible Side Effects and Safety Information

The safety profile of Amlodipine is formally classified by regulatory authorities based on the frequency of documented adverse reactions. These effects are often related to the medicine's primary action of widening blood vessels (vasodilation) and are grouped by the affected organ system.


Frequency-Classified Adverse Reactions

The most frequently reported effects are classified as Very Common or Common in official prescribing information.

Frequency Category Representative Adverse Reactions (Examples)
Very Common Oedema (Peripheral swelling)
Common Headache, Dizziness, Somnolence (Drowsiness), Flushing, Palpitations, Abdominal pain, Nausea, Fatigue
Uncommon Insomnia, Mood alteration, Tremor, Hypotension, Vomiting, Rash

Serious Adverse Reactions and Safety Constraints

Official regulatory documents also list rare but clinically significant adverse reactions, typically observed during widespread post-marketing use. These Very Rare events can affect the cardiovascular, hepatic, and dermatological systems, including Myocardial Infarction, Hepatitis, and severe skin reactions like Angioedema.

Safety data specifies that certain effects, particularly headache, flushing, and oedema, are commonly observed to be higher at the beginning of treatment or following a dose increase. Additionally, official labels include notes for special populations: clearance is typically decreased in older adults and those with hepatic impairment, leading to regulatory guidance for initial dosing in these groups. Use is formally contraindicated in cases of known hypersensitivity to Amlodipine.

Overdose and Emergency Response

Amlodine Overdose and When to Seek Help

Overdosage of Amlodipine is defined in regulatory documents by the potential for profound cardiovascular instability. The primary documented manifestation is marked and prolonged systemic hypotension, resulting from excessive peripheral vasodilatation. This significant drop in blood pressure can potentially escalate to shock with fatal outcome. Other serious signs listed in official labeling include changes in heart rate, such as reflex tachycardia or bradycardia. A rare, but severe, documented outcome is non-cardiogenic pulmonary oedema, which may have a delayed onset of 24 to 48 hours post-ingestion.

Emergency Action Required

Regulators mandate that individuals seek emergency medical attention immediately if an overdose is suspected or if severe signs such as collapse, seizure, trouble breathing, or unconsciousness occur. Due to the drug’s long elimination half-life, the resulting hemodynamic effects may be prolonged, requiring continuous hospital monitoring of cardiac and respiratory function. There is no specific antidote stated in regulatory information; therefore, management focuses entirely on active cardiovascular support. Official procedures for severe cases may include the use of intravenous calcium gluconate, a vasoconstrictor, gastric lavage, or activated charcoal to reduce absorption.

Therapeutic Uses of Amlodine

Amlodipine is applied across domains where additional symptomatic support is needed to help manage specific cardiovascular conditions. The main therapeutic uses include treating high blood pressure (hypertension) and certain forms of angina (chest pain) and coronary artery disease (CAD). This makes it relevant in contexts involving heightened systemic burden and helpful in situations requiring additional symptomatic assistance.

The medication is commonly used across conditions presenting with acute episodes, specifically helping with symptoms related to physical discomfort associated with angina. For patients, the medication may assist with easing the overall symptom burden during periods of heightened symptoms.

“The medicine may assist with maintaining functional stability and supports general well-being during symptomatic phases.”

In clinical scenarios, amlodipine assists with managing high blood pressure and supports maintaining functional stability. For patients experiencing chest pain, it contributes to improved comfort during periods of heightened symptoms. This supportive approach is often used during phases when symptoms become more noticeable.

Quick Fact: Relief for Symptoms Related to Physical Discomfort (The medication supports easing the overall symptom load associated with specific cardiovascular conditions.)

Regulatory References

  1. NIH MedlinePlus overview on Amlodipine

Eligibility and Restrictions for Use

Who Can and Cannot Use Amlodine?

The official eligibility for Amlodine is defined by authoritative regulatory documents and outlines specific patient groups who are permitted, restricted, or absolutely prohibited from using the medicine.

Absolute Contraindications (Must Not Use)

Amlodine is formally contraindicated in patients with a known hypersensitivity to amlodipine or other dihydropyridine derivatives. Use is also prohibited in patients with severe hypotension, cardiogenic shock, obstruction of the outflow tract of the left ventricle (e.g., high-grade aortic stenosis), and haemodynamically unstable heart failure following acute myocardial infarction.

Age-Group Eligibility

Age Group Eligibility Status (Official Regulatory Wording)
Children < 6 Years Use is not established; no data are available.
Children 6–17 Years Approved for the treatment of hypertension only.
Older Adults ≥ 65 Years Normal dosage regimens are recommended, but any increase in dose must be done with care.

Conditional Use and Restrictions

Patients with hepatic impairment (liver problems) require a cautious and potentially reduced starting dose due to altered drug clearance. While no dose adjustment is required for those with renal impairment, patients with congestive heart failure should use the medicine with caution. During pregnancy, use is allowed only if the potential benefit justifies the risk, and nursing mothers must make a decision to discontinue nursing or discontinue the drug.

What should I know about interactions with other medicines?

Amlodipine interactions are officially documented across several pharmacological and substance categories. Its systemic exposure is significantly increased when co-administered with strong or moderate CYP3A inhibitors, such as Diltiazem, Itraconazole, and Clarithromycin, which can potentially lead to enhanced effects. Conversely, the use of CYP3A inducers may decrease Amlodipine’s plasma concentration.

Amlodipine increases the systemic exposure of certain co-administered medicines, notably the cholesterol-lowering agent Simvastatin. Regulatory restrictions mandate that the Simvastatin dose must be limited to 20 mg daily when used concurrently. For immunosuppressants like Tacrolimus and Cyclosporine, Amlodipine may also increase their exposure, necessitating frequent monitoring of trough blood levels.

Pharmacodynamic interactions involve an additive hypotensive effect when Amlodipine is combined with other antihypertensive agents, alcohol (ethanol), or Phosphodiesterase Type 5 (PDE5) inhibitors, requiring attention to blood pressure response. Consumption of grapefruit or grapefruit juice is not recommended due to the potential for increased Amlodipine bioavailability. Finally, the regulatory profile includes the note that the prolonged clearance of Amlodipine in patients with hepatic impairment may increase the severity of these documented interactions.

Mechanism of Action

How Amlodipine Works

Amlodipine functions as a dihydropyridine calcium channel blocker, a core mechanistic domain that specifically modulates voltage-gated ion channels. The molecule interacts selectively with L-type calcium channels in the plasma membranes of both vascular smooth muscle and, to a lesser extent, cardiac muscle tissues.

Modulating Signal Transduction

Its pharmacodynamic action involves binding to these channels and inhibiting the transmembrane influx of extracellular calcium ions (Ca^2+) into the cells. This inhibition modifies molecular steps required for initiating smooth muscle contraction. By preventing the necessary rise in intracellular calcium, Amlodipine blocks the calcium-dependent activation of the contractile apparatus.

Physiological Consequence

The resulting physiological consequence is a reduction in the resting tone of the vasculature. This cascade leads to arteriolar vasodilation, which structurally translates into reduced resting tension within the vessel walls and a resulting decrease in systemic vascular resistance.

Dosage and Administration Information

How to Use Amlodine: Administration Guidelines

This section details the use of Amlodipine, focusing on the route, standard dosing, frequency, and administration instructions. This information does not cover safety, benefits, or mechanisms of action.


Official Dosing and Frequency

Amlodipine is approved for the oral route of administration as an immediate-release tablet. The medication is prescribed for long-term maintenance and is taken once daily (OD).

Administration Detail Adult Regimen (Hypertension/Angina) Specific Population Regimen
Starting Dose 5 mg once daily 2.5 mg once daily (Hepatic impairment or some older adults)
Maintenance Range 5 mg to 10 mg once daily 2.5 mg to 5 mg once daily (Pediatric 6–17 years)
Maximum Dose 10 mg once daily 5 mg once daily (Pediatric 6–17 years)

Administration Conditions and Timing

The following instructions describe when and how the tablet is taken:

  • Intake Time: The tablet can be taken without regard to food, meaning it can be consumed before, during, or after a meal, simplifying the daily schedule.
  • Dose Adjustment: Any change to the dose (titration) should typically be done at intervals of at least 7 to 14 days. This timeframe allows the drug to fully reach a stable level in the body before the response is assessed.
  • Missed Dose: If a dose is missed, it should be taken as soon as the patient remembers, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped. Double doses should not be taken to compensate.

Recent Clinical Evidence

Research evidence / Overview of studies for Amlodine


Evidence for Use in Managing High Blood Pressure

The primary research base for Amlodine includes numerous Randomized Controlled Trials (RCTs) and large meta-analyses used to evaluate clinical measurements in populations with high blood pressure, known as hypertension. These studies were designed to measure changes in Systolic and Diastolic Blood Pressure (BP) readings, often over short-term periods. Research has explored Amlodine in trials that monitored outcomes alongside an inactive substance (placebo) as well as alongside other established types of blood pressure medications.

Long-term studies, which sometimes followed adult populations for several years, also monitored the occurrence rates of major cardiovascular events, such as stroke and myocardial infarction. However, long-term data focusing on specific metrics like all-cause mortality require continuous analysis across large patient groups.


Research in Angina and Coronary Artery Disease

Amlodine has been studied for its use in two related cardiovascular contexts: examining outcomes in chronic forms of angina (chest pain) and evaluating specific event rates in patients diagnosed with Coronary Artery Disease (CAD).

For angina, controlled clinical trials were conducted to examine outcomes related to physical discomfort. Researchers studied how the frequency of anginal attacks changed over time and monitored the consumption of other medications taken to address symptoms. Studies reported measurements of a change in the frequency of discomfort related to angina in the observed populations. For patients with documented CAD, multi-year trials monitored the occurrence rate of hospitalization due to angina and the requirement for a coronary revascularization procedure.


Evidence in Special Populations and Research Gaps

Research has explored Amlodine in several specific patient cohorts. For pediatric patients (ages 6–17), studies were conducted to examine outcomes related to blood pressure levels over a short-term duration. However, the overall volume of evidence for children is limited compared to the data for adults, and long-term effects or outcomes are not fully established.

The evidence base is limited for uses in rare or specialized populations, such as in patients with myocardial iron overload, where sample sizes were modest and the data are still emerging. Follow-up durations, while long in some trials, were limited in others, and the certainty remains low for certain key outcomes.

Key Studies & References

  1. Label: AMLODIPINE BESYLATE tablet - DailyMed - NIH (Regulatory Documentation)

Frequently Asked Questions (FAQ)

Common questions about Amlodine (FAQ)


Q: What is the typical timeframe before Amlodine starts to fully control blood pressure?

A: Amlodine is a long-acting medication. According to official product information, consistent blood levels, known as steady-state plasma levels, are typically reached after about 7 to 8 days of consecutive daily dosing. This timeframe is often when the medication begins to fully exert its stable therapeutic effect.


Q: Why does Amlodine cause ankle or leg swelling, and can this side effect be managed?

A: Ankle or leg swelling (oedema) is listed in official documents as a Very Common side effect. This occurs because the medication widens the blood vessels, causing fluid to pool in the lower extremities. While the label notes this effect, any management strategy for this side effect should be discussed with a healthcare provider.


Q: Can Amlodine cause an increase in heart rate or palpitations?

A: Regulatory documents indicate that palpitations (a fluttering or thumping heart feeling) are a Common side effect. While acute administration may increase heart rate, official studies show that chronic oral administration in clinical studies did not cause clinically significant changes in heart rate.


Q: Can Amlodine cause weight gain or weight loss?

A: Official adverse reaction profiles list both weight increase and weight decrease as potential effects of Amlodine. However, these changes were not commonly reported during the clinical trials.


Q: Is there a risk of developing a long-term side effect, such as gum swelling (gingival hyperplasia), while on Amlodine?

A: Though rare, gingival hyperplasia (gum swelling or overgrowth) is listed in official adverse reaction profiles. This effect is known to be associated with the calcium channel blocker class of medicines, which Amlodine belongs to.


Q: Does Amlodine affect sleep, causing insomnia or unusual dreams?

A: Official prescribing information lists insomnia (difficulty sleeping) as an Uncommon adverse reaction. Additionally, abnormal dreams are also cited in some regulatory adverse reaction profiles.


Q: What should be done if someone feels dizzy or lightheaded after taking Amlodine?

A: Dizziness is a Common side effect of Amlodine. Official warnings indicate that caution should be exercised, particularly when starting treatment or increasing the dose, as the ability to react may be impaired.


Q: Can Amlodine cause muscle stiffness or tremors as a side effect?

A: Official safety data lists tremor (involuntary shaking) as an Uncommon adverse reaction. Additionally, muscle cramps are also included in the reported adverse reaction profile of Amlodine.


Q: Is it normal to have a change in mood or feel depressed while taking Amlodine?

A: According to official regulatory documents, mood changes and feelings of depression are listed as potential adverse reactions. These effects are not common but have been reported in the drug's safety profile.


Q: Is Amlodine considered a first-line treatment for high blood pressure?

A: Yes, regulatory bodies, such as the FDA, designate Amlodine as a first-line agent for treating high blood pressure (hypertension). This classification reflects its established efficacy and common use in initial therapy.


Q: What is the difference between Amlodine and other types of blood pressure medications, like ACE inhibitors or beta-blockers?

A: Amlodine is a Calcium Channel Blocker with a distinct mechanism of action that works primarily by widening blood vessels. Official documents state that it can be used safely in combination with other classes like ACE inhibitors and beta-blockers to achieve blood pressure control.


Q: Why is Amlodine sometimes prescribed along with other blood pressure medicines?

A: Amlodine is officially indicated for use alone or in combination with other antihypertensive agents. It is often combined with other medicines because its unique action provides an additive hypotensive effect, helping to achieve the target blood pressure when a single medicine is not enough.


Q: Is Amlodine effective for all types of angina (chest pain)?

A: The official product labeling indicates that Amlodine is specifically approved for the treatment of chronic stable angina and a specific type of chest pain called vasospastic angina (Prinzmetal's or Variant angina).


Q: Is it normal for Amlodine to cause increased urination, especially at night?

A: Official adverse reaction lists include both micturition frequency (increased urination) and nocturia (waking up to urinate at night) as reported effects of the medication.


Q: Can Amlodine affect blood sugar levels in people who have diabetes?

A: Though rare, the official adverse reaction profile for Amlodine lists hyperglycaemia (an abnormally high blood sugar level). This means it has been reported as a potential side effect.


Q: What are the risks of suddenly stopping Amlodine treatment?

A: Amlodine is intended for long-term maintenance of blood pressure. Abruptly stopping treatment can lead to a significant rise in blood pressure, which is associated with an increased risk of serious cardiovascular events. The decision to stop treatment should always be discussed with a healthcare provider.


Q: What happens if a dose of Amlodine is missed?

A: If a dose is missed, regulatory instructions indicate it should be taken as soon as a person remembers, unless it is almost time for the next scheduled dose. Official administration guidelines warn against taking a double dose to compensate for a missed dose.


Q: Is it better to take Amlodine in the morning or at night for the best blood pressure control?

A: Official regulatory documents do not recommend a specific time of day (morning or night) for optimal blood pressure control. The medication should be taken once daily at approximately the same time each day, and it can be taken with or without food.


Q: Are there any special monitoring tests (like blood tests) required when taking Amlodine?

A: Routine blood tests specifically for monitoring Amlodine itself are not typically mandated in the official label. However, if Amlodine is taken concurrently with certain immunosuppressant drugs (like Tacrolimus), official documents require careful monitoring of those other drug levels.


Q: Can Amlodine worsen chest pain or cause a heart attack in rare cases?

A: Official safety documents list Myocardial Infarction (heart attack) as a Very Rare adverse reaction. There have also been reports of a worsening of angina (chest pain) occurring, particularly when starting the medicine or increasing the dose.


Q: Are there any racial or ethnic differences in how Amlodine works or its effectiveness?

A: Studies noted in regulatory documents have suggested that there may be ethnic differences in the initial dosing requirements for Amlodine. For example, lower starting doses may be considered appropriate for some Asian patients.


Q: What precautions should be taken if Amlodine is prescribed to someone who already has very low blood pressure (hypotension)?

A: Amlodine is formally contraindicated (not recommended for use) in patients with severe hypotension. Because the medicine can cause a further reduction in blood pressure, it is important to use caution when it is prescribed to people who already have low blood pressure.


Q: Does Amlodine affect kidney function or require dose adjustments for kidney issues?

A: Official documents state that Amlodine does not require any dose adjustment for people who have renal (kidney) impairment. This suggests the medicine is typically safe for use in this population without special dosing.


Q: What is the half-life of Amlodine, and what does this mean for daily dosing?

A: Amlodine has a long terminal elimination half-life of approximately 30–50 hours. This long duration means the medicine stays in the body for a long time, which is why it is officially indicated and appropriate for once-daily dosing.

How should Amlodine be stored and disposed of?

Storage and Disposal Requirements for Amlodipine

Amlodipine tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication should be kept in its original container, which must remain tightly closed to protect it from moisture. It is a mandatory requirement to store the tablets out of the sight and reach of children to prevent accidental ingestion. Unused or expired amlodipine should be disposed of using an official drug take-back program or by following specific household disposal guidelines. Regulatory instructions forbid flushing the tablets down the toilet or pouring them down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlodine found in:

A-Z Index: